559 related articles for article (PubMed ID: 29674135)
21. Association between HbA1c and cardiovascular disease mortality in older Hong Kong Chinese with diabetes.
Xu L; Chan WM; Hui YF; Lam TH
Diabet Med; 2012 Mar; 29(3):393-8. PubMed ID: 21916977
[TBL] [Abstract][Full Text] [Related]
22. Antihyperglycaemic treatment patterns, observed glycaemic control and determinants of treatment change among patients with type 2 diabetes in the United Kingdom primary care: a retrospective cohort study.
Maguire A; Mitchell BD; Ruzafa JC
BMC Endocr Disord; 2014 Aug; 14():73. PubMed ID: 25163796
[TBL] [Abstract][Full Text] [Related]
23. Effects of the Norfolk diabetes prevention lifestyle intervention (NDPS) on glycaemic control in screen-detected type 2 diabetes: a randomised controlled trial.
Sampson M; Clark A; Bachmann M; Garner N; Irvine L; Howe A; Greaves C; Auckland S; Smith J; Turner J; Rea D; Rayman G; Dhatariya K; John WG; Barton G; Usher R; Ferns C; Pascale M;
BMC Med; 2021 Aug; 19(1):183. PubMed ID: 34407811
[TBL] [Abstract][Full Text] [Related]
24. Glycaemic control and sepsis risk in adults with type 1 diabetes.
Balintescu A; Lind M; Andersson Franko M; Oldner A; Cronhjort M; Eliasson B; Svensen C; Mårtensson J
Diabetes Obes Metab; 2023 Jul; 25(7):1942-1949. PubMed ID: 36949627
[TBL] [Abstract][Full Text] [Related]
25. International comparison of glycaemic control in people with type 1 diabetes: an update and extension.
Prigge R; McKnight JA; Wild SH; Haynes A; Jones TW; Davis EA; Rami-Merhar B; Fritsch M; Prchla C; Lavens A; Doggen K; Chao S; Aronson R; Brown R; Ibfelt EH; Svensson J; Young R; Warner JT; Robinson H; Laatikainen T; Rautiainen P; Delemer B; Souchon PF; Diallo AM; Holl RW; Schmid SM; Raile K; Tigas S; Bargiota A; Zografou I; Luk AOY; Chan JCN; Dinneen SF; Buckley CM; Kgosidialwa O; Cherubini V; Gesuita R; Strele I; Pildava S; Veeze H; Aanstoot HJ; Mul D; Jefferies C; Cooper JG; Løvaas KF; Battelino T; Dovc K; Bratina N; Eeg-Olofsson K; Svensson AM; Gudbjornsdottir S; Globa E; Zelinska N
Diabet Med; 2022 May; 39(5):e14766. PubMed ID: 34890078
[TBL] [Abstract][Full Text] [Related]
26. Patient-level predictors of achieving early glycaemic control in Type 2 diabetes mellitus: a population-based study.
Svensson E; Baggesen LM; Thomsen RW; Lyngaa T; Pedersen L; Nørrelund H; Buhl ES; Haase CL; Johnsen SP
Diabet Med; 2016 Nov; 33(11):1516-1523. PubMed ID: 27412570
[TBL] [Abstract][Full Text] [Related]
27. Distinct trajectories of HbA
Rathmann W; Schwandt A; Hermann JM; Kuss O; Roden M; Laubner K; Best F; Ebner S; Plaumann M; Holl RW;
Diabet Med; 2019 Nov; 36(11):1468-1477. PubMed ID: 31392761
[TBL] [Abstract][Full Text] [Related]
28. Long term risk of severe retinopathy in childhood-onset type 1 diabetes: a data linkage study.
White M; Sabin MA; Magnussen CG; O'Connell MA; Colman PG; Cameron F
Med J Aust; 2017 May; 206(9):398-401. PubMed ID: 28490305
[TBL] [Abstract][Full Text] [Related]
29. Effects of canagliflozin compared with placebo on major adverse cardiovascular and kidney events in patient groups with different baseline levels of HbA
Young TK; Li JW; Kang A; Heerspink HJL; Hockham C; Arnott C; Neuen BL; Zoungas S; Mahaffey KW; Perkovic V; de Zeeuw D; Fulcher G; Neal B; Jardine M
Diabetologia; 2021 Nov; 64(11):2402-2414. PubMed ID: 34448033
[TBL] [Abstract][Full Text] [Related]
30. Associations of HbA1c and educational level with risk of cardiovascular events in 32,871 drug-treated patients with Type 2 diabetes: a cohort study in primary care.
Östgren CJ; Sundström J; Svennblad B; Lohm L; Nilsson PM; Johansson G
Diabet Med; 2013 May; 30(5):e170-7. PubMed ID: 23350893
[TBL] [Abstract][Full Text] [Related]
31. Risk of first stroke in people with type 2 diabetes and its relation to glycaemic control: A nationwide observational study.
Zabala A; Darsalia V; Holzmann MJ; Franzén S; Svensson AM; Eliasson B; Patrone C; Nyström T; Jonsson M
Diabetes Obes Metab; 2020 Feb; 22(2):182-190. PubMed ID: 31576643
[TBL] [Abstract][Full Text] [Related]
32. Changes in HbA1c level over a 12-week follow-up in patients with type 2 diabetes following a medication change.
Hirst JA; Stevens RJ; Farmer AJ
PLoS One; 2014; 9(3):e92458. PubMed ID: 24667212
[TBL] [Abstract][Full Text] [Related]
33. Good glycaemic control is associated with a better prognosis in breast cancer patients with type 2 diabetes mellitus.
Chang YL; Sheu WH; Lin SY; Liou WS
Clin Exp Med; 2018 Aug; 18(3):383-390. PubMed ID: 29572669
[TBL] [Abstract][Full Text] [Related]
34. Diabetes Complications at Presentation and One Year by Glycated Haemoglobin at Diagnosis in a Multiethnic and Diverse Socioeconomic Population: Results from the South London Diabetes Study.
Azam M; Marwood L; Ismail K; Evans T; Sivaprasad S; Winkley K; Amiel SA
J Diabetes Res; 2015; 2015():587673. PubMed ID: 26090473
[TBL] [Abstract][Full Text] [Related]
35. Metabolic memory and all-cause death in community-based patients with type 2 diabetes: the Fremantle Diabetes Study.
Davis TM; Chubb SA; Bruce DG; Davis WA
Diabetes Obes Metab; 2016 Jun; 18(6):598-606. PubMed ID: 26936654
[TBL] [Abstract][Full Text] [Related]
36. Peripheral arterial disease and type 2 diabetes: Older patients still exhibit a survival benefit from glucose control.
Höbaus C; Herz CT; Wrba T; Koppensteiner R; Schernthaner GH
Diab Vasc Dis Res; 2020; 17(2):1479164120914845. PubMed ID: 32308023
[TBL] [Abstract][Full Text] [Related]
37. Associations between usual glycated haemoglobin and cardiovascular disease in patients with type 2 diabetes mellitus: A 10-year diabetes cohort study.
Wan EY; Yu EY; Chen JY; Wong IC; Chan EW; Lam CL
Diabetes Obes Metab; 2020 Dec; 22(12):2325-2334. PubMed ID: 32744402
[TBL] [Abstract][Full Text] [Related]
38. Intermediate hyperglycaemia to predict progression to type 2 diabetes (ELSA-Brasil): an occupational cohort study in Brazil.
Schmidt MI; Bracco PA; Yudkin JS; Bensenor IM; Griep RH; Barreto SM; Castilhos CD; Duncan BB
Lancet Diabetes Endocrinol; 2019 Apr; 7(4):267-277. PubMed ID: 30803929
[TBL] [Abstract][Full Text] [Related]
39. Intermediate hyperglycaemia and 10-year mortality in resource-constrained settings: the PERU MIGRANT Study.
Lazo-Porras M; Ruiz-Alejos A; Miranda JJ; Carrillo-Larco RM; Gilman RH; Smeeth L; Bernabé-Ortiz A
Diabet Med; 2020 Sep; 37(9):1519-1527. PubMed ID: 32181918
[TBL] [Abstract][Full Text] [Related]
40. Sex-specific impact of major depressive disorder on 12-year change in glycaemic status: Results from a nationwide cohort study of adults without diabetes in Germany.
Nübel J; Truthmann J; Heidemann C; Du Y; Paprott R; Hapke U; Kruse J; Scheidt-Nave C; Baumert J
Diabet Med; 2022 Mar; 39(3):e14767. PubMed ID: 34890066
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
